La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Quanterix a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Quanterix..

Quanterix (NASDAQ:QTRX) Azioni, Catena delle Opzioni

Quanterix

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

AerCap Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>) has outperformed the market over the past 15 years by 4.65% on an annualized basis producing an average annual return of 17.07%. Currently, AerCap Holdings has a market capitalization of $20.86 billion. 
Buying $100 In AER: If an investor had bought $100 of AER stock 15 years ago, it would be worth $1,070.23 today based on a price of $115.05 for AER at the time of writing.
<h3>AerCap Holdings's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751497214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

ForSight Robotics, an <a href="https://www.benzinga.com/news/topics/25/06/46056435/missiles-are-landing-in-the-heart-of-israeli-high-tech-says-ceo-but-200m-backed-startups-dream-and-sentra-stay-operational">Israeli</a> startup aiming to automate cataract and eye surgery,<a href="https://www.businesswire.com/news/home/20250624465565/en/ForSight-Robotics-Secures-%24125M-in-Series-B-Funding-Addressing-Global-Surgeon-Shortage-and-Exploding-Demand-for-Ophthalmic-Surgery"> announced</a> Tuesday that it raised $125 million to expand its precision robotics platform, Oryom.
The round was led by Eclipse Ventures, with participation from surgical robotics legend Fred Moll, co-founder of Intuitive Surgical, and Moshe Shoham, a Technion professor and pioneer behind multiple robotics companies including Mazor, which was acquired by Medtronic for $1.6 billion,<a href="https://www.forbes.com/sites/amyfeldman/2025/06/24/startup-forsight-wants-its-robots-to-operate-on-your-eyeballs-cataract-surgery/"> Forbes</a> reports.
Don't Miss:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
<h2 class="wp-block-heading">Inside ForSight's Mission To Solve The Global Cataract Crisis</h2>
Forbes says that more than 4 million cataract surgeries are performed each year in the U.S. alone. Yet, according to a<a href="https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment"> World Health Organization</a> report, over 1 billion people globally suffer from preventable <a href="https://www.benzinga.com/markets/large-cap/25/06/45814068/novo-nordisks-wegovy-tied-to-increased-risk-of-rare-vision-loss-disorder-european-regulators-say">vision loss</a>. As the population ages and the number of ophthalmologists declines, a gap is forming that traditional medical systems can't fill.
"There is no human way to close the gap as we see it," Dr. Joseph Nathan, ForSight co-founder and chief medical officer, told Forbes. "Robotics will have to take over."
Cataract surgery is a highly precise procedure that involves operating within extremely small spaces, requiring steady hands and dexterous control, according to Forbes. ForSight says its Oryom platform is designed specifically to handle the complexity and consistency of ophthalmic procedures using AI-based algorithms, computer vision, and micromechanics to enhance surgical precision and reduce the physical strain on surgeons.
Over the past year, more than two dozen ophthalmic surgeons have used the platform to successfully perform hundreds of procedures on animal eye models as part of the system's development and testing phase. Forbes reports that ForSight has specifically tested its robotic system on porcine eyes due to their close anatomical similarity to human eyes, a common method used in ophthalmic surgical training.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
The company says it has yet to perform surgery on a human patient, but expects to begin clinical trials by the end of the year. Early conversations with the Food and Drug Administration are already underway, and the new funding will carry the company through its regulatory process.
<h2 class="wp-block-heading">ForSight is Powered by the Titans of Surgical Robotics</h2>
ForSight was born out of Israel's Technion Institute, where Shoham, Nathan, and co-founder Daniel Glozman combined decades of expertise in medical engineering, research and development, and commercialization. Shoham's previous students have gone on to lead Medtronic's robotics division and build multi-billion-dollar exits. Moll and Shoham, often called "the godfathers of surgical robotics," now advise the company strategically, Forbes reports.
"There is only one procedure that is done more than cataract surgery and that is blood drawing," Moll told Forbes. "As far as real surgical technique [that could be helped by robotics], cataract surgery is at the top of the list."
With its third-generation prototype complete, ForSight is already preparing to expand its platform's capabilities beyond cataracts. Forbes says that future use cases include retinal procedures, glaucoma treatments, and complex eye surgeries that currently only a handful of surgeons in the world are qualified to perform.
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation.&nbsp;</a>
<h2 class="wp-block-heading">Can this Cataract Robot Solve the Vision Surgeon Shortage? ForSight Thinks So</h2>
ForSight's Oryom system provides a potential answer to a looming global health crisis. According to the company, there are only 31.7 ophthalmologists and 14.1 cataract surgeons per million people globally, highlighting a significant gap between demand and surgical capacity. This surgeon shortage, combined with rising rates of preventable blindness, suggests that millions may not receive timely care.
A 2020 study published in the<a href="https://pubmed.ncbi.nlm.nih.gov/31266774/"> British Journal of Ophthalmology</a>, further confirms that lower-income countries average just 3.7 ophthalmologists per million people, compared to 76.2 in high-income nations, underscoring the disparity in access to eye care worldwide.
By automating precision eye surgery, ForSight is betting on a future where access to vision care is no longer limited by geography or availability of human doctors. If successful, the company may become the Intuitive Surgical of ophthalmology.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap'

<a href="https://www.wsj.com/business/media/netflix-explores-music-shows-and-celebrity-interviews-as-part-of-live-tv-push-f2ac508f" title="https://www.wsj.com/business/media/netflix-explores-music-shows-and-celebrity-interviews-as-part-of-live-tv-push-f2ac508f">https://www.wsj.com/business/media/netflix-explores-music-shows-and-celebrity-interviews-as-part-of-live-tv-push-f2ac508f</a>

NFLX

SPOT

Reported Earlier: 'Netflix Explores Music Shows and Celebrity Interviews in Unscripted TV Push' - WSJ

KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) has outperformed the market over the past 20 years by 7.53% on an annualized basis producing an average annual return of 16.0%. Currently, KLA has a market capitalization of $122.21 billion. 
Buying $1000 In KLAC: If an investor had bought $1000 of KLAC stock 20 years ago, it would be worth $19,894.17 today based on a price of $919.68 for KLAC at the time of writing.
<h3>KLA's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751496315_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KLAC

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

OpenAI publicly stated on Wednesday that the so-called "OpenAI tokens" offered by Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) are not OpenAI equity and clarified it has no partnership or involvement with Robinhood <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46186180/raoul-pal-says-robinhood-letting-users-trade-openai-spacex-through-blockchain-is-democratization-of-finance-end-of-public-vs-private-markets-has-begun">regarding the product. </a>
The Details: OpenAI Newsroom said in a <a href="https://x.com/OpenAINewsroom/status/1940502391037874606">post </a>on X that any transfer of its equity requires company approval, which was not granted in this case, and advised users to be cautious.&nbsp;
"These &#8216;OpenAI tokens&#8217; are not OpenAI equity. We did not partner with Robinhood, were not involved in this, and do not endorse it. Any transfer of OpenAI equity requires our approval — we did not approve any transfer. Please be careful," the company wrote in the post. 
Read Next: <a href="https://www.benzinga.com/markets/large-cap/25/07/46223791/elon-musks-stupid-actions-will-be-teslas-nail-in-the-coffin-ross-gerber-warns?utm_source=articleShare">Elon Musk&#8217;s &#8216;Stupid&#8217; Actions Will Be Tesla&#8217;s &#8216;Nail In The Coffin,&#8217; Ross Gerber Warns</a>
Robinhood announced the launch of the tokenized shares on Monday as part of a broader initiative around tokenized equities, staking and blockchain infrastructure.&nbsp;
"These tokens give retail investors indirect exposure to private markets, opening up access, and are enabled by Robinhood's ownership stake in a special purpose vehicle," a Robinhood spokesperson said in response to OpenAI's post, per<a href="https://www.cnbc.com/2025/07/02/openai-robinhood-tokens.html"> CNBC</a>.&nbsp;
Elon Musk, an original co-founder of OpenAI who has openly feuded with its CEO Sam Altman, responded to OpenAI's post.&nbsp;
"Your ‘equity' is fake," <a href="https://x.com/elonmusk/status/1940519798376730893">wrote</a> Musk.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Your "equity" is fake
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1940519798376730893?ref_src=twsrc%5Etfw">July 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What Else: Robinhood shares<a href="https://www.benzinga.com/trading-ideas/movers/25/07/46225339/robinhood-stock-surges-to-all-time-high-on-aggressive-crypto-expansion-whats-going-on"> hit a new</a> all-time high Wednesday, following its recent series of major announcements revealing a more comprehensive push into the cryptocurrency space.
KeyBanc Capital Markets on Monday increased its price target for the stock to $110 from $60, maintaining an Overweight rating. KeyBanc analysts cited Robinhood's "first-rate innovation" and "TAM expansion" as primary drivers for the upgrade.
HOOD: Robinhood shares were down 1.71% at $96.30 in Wednesday's extended trading, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46199580/microsoft-rivian-intel-slash-jobs-in-june-tech-layoff-spree?utm_source=articleShare">Microsoft, Rivian, Intel Slash Jobs In June Tech Layoff Spree</a></li>
</ul>
Image: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Management

After-Hours Center

Movers

Tech

HOOD

OpenAI Says Tokens Are Not Equity, No Partnership With Robinhood: Musk Says AI Company's Equity 'Is Fake'

In a <a href="https://youtu.be/Mza5tTgh9hA?si=t8kQpBKpfYDgY-xK">2015 interview with journalist Graham Basinger</a>, Shaquille O'Neal peeled back the curtain on a side of his story you don't see in highlight reels. Not the dunks. Not the trophies. The moment he found out he was $80,000 in the hole—before he'd even played a single NBA game.
"I spend it in one day," he said, referring to the $1 million endorsement deal he landed before the draft. The spending spree started with a black Mercedes—$150,000, no questions asked. "No negotiations," he said. "Guy could have told me $200,000 and I would've bought it."
Then came one for his dad. Then one for his mom. Suits, jewelry, electronics, a sound system with a beeper-connected alarm. "A couple days later, I got a call from the bank," Shaq said. The manager, a family friend, asked if he could read a bank statement. "I was 80,000 in the hole," Shaq admitted. "And I was real embarrassed."
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
But that call changed everything. "Son," the banker told him, "I watched you play here in high school. You're bright. I don't want you to be like all these other athletes."
That stuck.
Shaq started meeting with financial advisors—but many raised red flags. "I can remember an old-timer saying, ‘It was too good to be true. Don't do it,'" Shaq recalled. That voice in his head helped him dodge flashy promises and zero in on the right person.
He was young, rich, and honest about one simple truth: nobody had taught him how money really worked. He didn't understand things like FICA or taxes—he thought that million-dollar check was exactly that. And like a lot of people in their early 20s, he learned by making expensive mistakes.
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
Then came the man who changed his life: "One little, small, beautiful Jewish man" who told him, simply, "I'm into savings bonds. We're gonna start a subchapter S corporation for your family." Shaq's response? "Shalom, I'm going with you, sir."
That advisor, Lester Knispel, became like a second father. And when Shaq started slipping into old habits—like the time he tried to <a href="https://www.benzinga.com/news/25/01/43397569/shaq-once-blew-600000-on-two-rolls-royces-because-mike-tyson-bought-three-and-he-didnt-want-to-be-outdone-by-him">outdo Mike Tyson at a Rolls-Royce dealership</a> and dropped $600,000—Lester was the one who reeled him back in.
It worked. Big time.
Shaq learned. Not just how to protect his money, but how to grow it. He became an <a href="https://www.benzinga.com/general/sports/25/03/44449022/shaq-accidentally-invested-250000-in-this-company-now-its-value-is-skyrocketing-my-only-regret-i-wish-i-would-have-bought-more">early investor in Google</a>, took a <a href="https://www.benzinga.com/startups/24/09/40677330/shaq-refused-to-pay-80-000-for-security-and-made-a-surprising-choice-he-invested-in-a-company-bezos">stake in Ring</a> before Amazon scooped it up for $1 billion, and quietly built an empire. He owns dozens of franchises—from fast food to fitness—and has parlayed his brand into everything from TV to tech.
See Also: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a>
"People always talk about athletes going broke," he once said. "I made sure I wouldn't be one of them."
These days, Shaq isn't just spending smart—he's sharing the playbook. He regularly offers advice to young athletes and everyday folks alike, stressing basics like living below your means, getting help from professionals, and avoiding credit card debt. "It's not about how much you make," he told CNBC. "<a href="https://www.benzinga.com/personal-finance/24/10/41305175/nba-legend-shaq-says-you-should-save-75-of-your-paycheck-its-not-about-how-much-you-make-its-abo">It's about how much you keep</a>."
Whether it's tipping big, buying strangers appliances at Walmart, or just telling fans to "invest in what you know," Shaq isn't just generous with his money—he's generous with his lessons.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

Shaq Was '$80,000 In The Hole' When He Took An Old Timer's Advice — Hired 'A Small, Beautiful Man' Who Put His Money in Bonds And An S Corp

Curtiss-Wright (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CW#NYSE">CW</a>) has outperformed the market over the past 10 years by 9.41% on an annualized basis producing an average annual return of 20.95%. Currently, Curtiss-Wright has a market capitalization of $18.08 billion. 
Buying $100 In CW: If an investor had bought $100 of CW stock 10 years ago, it would be worth $667.29 today based on a price of $479.65 for CW at the time of writing.
<h3>Curtiss-Wright's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751495412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Curtiss-Wright Stock In The Last 10 Years

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702" target="_blank" rel="noreferrer noopener">&nbsp;and individual tickers.</a>
The 2025 year is half over with July now here, which is likely hard for many to believe. Here is a look at the most searched stocks on Benzinga Pro for the first half of 2025. Current prices and year-to-date performance are based on June 30 market close prices and do not include dividends.
1. SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)
<ul class="wp-block-list">
<li>Current Price: $617.85</li>
<li>52-Week Range: $481.81 to $619.22</li>
<li>Year-to-Date Return: +5.7%</li>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank">2024 Benzinga Pro Search Rank</a>: 3rd</li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank">April</a>/<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45750724/exclusive-mays-20-most-searched-tickers-on-benzinga-pro-where-do-apple-palantir-coreweave-nvidia-rank">May</a>/<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46205646/exclusive-june-20-most-searched-tickers-on-benzinga-pro-where-do-coreweave-nvidia-apple-stock-rank">June </a>2025 Search Rank: 1st/1st/1st</li>
</ul>
2. Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
<ul class="wp-block-list">
<li>Current Price: $317.66</li>
<li>52-Week Range: $182 to $488.54</li>
<li>Year-to-Date Return: -16.3%</li>
<li>2024 Benzinga Pro Search Rank: 2nd &nbsp;</li>
<li>April/May/June 2025 Search Rank: 3rd/4th/2nd</li>
</ul>
3. NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)
<ul class="wp-block-list">
<li>Current Price: $157.99</li>
<li>52-Week Range: $86.63 to $158.71</li>
<li>Year-to-Date Return: +14.2%</li>
<li>2024 Benzinga Pro Search Rank: 1st</li>
<li>April/May/June 2025 Search Rank: 2nd/2nd/3rd</li>
</ul>
4. Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)
<ul class="wp-block-list">
<li>Current Price: $136.32</li>
<li>52-Week Range: $21.23 to $148.22</li>
<li>Year-to-Date Return: +81.3%</li>
<li>2024 Benzinga Pro Search Rank: 7th</li>
<li>April/May/June 2025 Search Rank: 7th/3rd/4th</li>
</ul>
5. Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>)
<ul class="wp-block-list">
<li>Current Price: $49.85</li>
<li>52-Week Range: $13.47 to $72.98</li>
<li>Year-to-Date Return: +97.8%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>April/May/June 2025 Search Rank: 8th/9th/8th</li>
</ul>
6. UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)
<ul class="wp-block-list">
<li>Current Price: $311.97</li>
<li>52-Week Range: 248.88 to $630.73</li>
<li>Year-to-Date Return: -38.2%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>April/May/June 2025 Search Rank: Not in Top 20/5th/Not in Top 20</li>
</ul>
7. CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>)
<ul class="wp-block-list">
<li>Current Price: $163.06</li>
<li>52-Week Range: $33.52 to $187</li>
<li>Year-to-Date Return: +307.8%</li>
<li>2024 Benzinga Pro Search Rank: Not Public</li>
<li>April/May/June 2025 Search Rank: Not in Top 20/11th/6th</li>
</ul>
8. Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)
<ul class="wp-block-list">
<li>Current Price: $49.01</li>
<li>52-Week Range: $17.25 to $96.33</li>
<li>Year-to-Date Return: +63.1%</li>
<li>2024 Benzinga Pro Search Rank: 4th</li>
<li>April/May/June 2025 Search Rank: 9th/Not in Top 20/Not in Top 20</li>
</ul>
9. Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)
<ul class="wp-block-list">
<li>Current Price: $141.90</li>
<li>52-Week Range: $76.48 to $187.28</li>
<li>Year-to-Date Return: +17.6%</li>
<li>2024 Benzinga Pro Search Rank: 6th</li>
<li>April/May/June 2025 Search Rank: 18th/14th/9th</li>
</ul>
10. Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>)
<ul class="wp-block-list">
<li>Current Price: $55.99</li>
<li>52-Week Range: $5.35 to $73.55</li>
<li>Year-to-Date Return: +156.3%</li>
<li>2024 Benzinga Pro Search Rank: Not in Top 20</li>
<li>April/May/June 2025 Search Rank: Not in Top 20/12th/10th</li>
</ul>
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46198021/nvidia-vs-microsoft-vs-apple-which-stock-reaches-4-trillion-first">Nvidia Vs. Microsoft Vs. Apple: Which Stock Reaches $4 Trillion First?</a>
Honorable Mentions:&nbsp;The following stocks were the 11th&nbsp;to 20th&nbsp;most-searched tickers on&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent030425&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;for the first six months of 2025.
11. Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)
12. Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
13. Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)
14. Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)
15. Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
16. SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>)
17. D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>)
18. Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>)
19. Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>)
20. Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>)
Why It's Important: The top 10 list for the first six months of 2025 looked similar to the month of June, with eight of the companies the same.
UnitedHealth Group, which has appeared in only one top 20 over the past three months, ranked sixth thanks to the strong interest in the ticker at the start of the year.
Super Micro Computer similarly ranked eighth for the first half of 2025 despite only a ninth place rank in April and not being in the top 20 in May or June. The stock was particularly popular during the first three months of the year.
If the top 10 holds steady for the rest of the year, the top three stocks would match the 2024 year, but in a different order. In 2024, it was Nvidia ranked first, followed by Tesla and the SPDR S&amp;P 500 ETF Trust. The three stocks now rank in opposite order through the first six months of the year.
Outside of the top 10 there weren't many huge surprises with themes such as cryptocurrency, AI and quantum computing being strong in the first six months of 2025.
Apple ended the first half of the year ranked 12th, despite previously ranking in the top 10 in several months to start the year. Other Mag 7 stocks such as Amazon and Meta also ranked in the 11 to 20. Alphabet ranked just outside of the top 20 for the first half of the year at 22nd place. Nowhere to be found in the top 25 was Microsoft, a member of the Mag 7 and the second most valuable company in the world.
Stay tuned <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702" target="_blank" rel="noreferrer noopener">to Benzinga Pro </a>for more market-moving news and to track the top tickers.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/07/46200141/dow-jones-2025-first-half-scoreboard-top-10-winners-losers-where-do-nvidia-apple-stock-rank">Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?</a></li>
</ul>

Long Ideas

Exclusives

AAPL

AMZN

ASST

COIN

CRCL

CRWV

Hims & Hers Health, Inc. Class A Common Stock

HIMS

NVDA

OKLO

PLTR

PONY

QBTS

SBET

SMCI

TSLA

EXCLUSIVE: 2025's First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank?

<a href="https://www.bloomberg.com/news/articles/2025-07-02/starbucks-dangles-6-million-stock-grants-to-speed-up-turnaround" title="https://www.bloomberg.com/news/articles/2025-07-02/starbucks-dangles-6-million-stock-grants-to-speed-up-turnaround">https://www.bloomberg.com/news/articles/2025-07-02/starbucks-dangles-6-million-stock-grants-to-speed-up-turnaround</a>

SBUX

'Starbucks Dangles $6 Million Stock Grants to Executives to Speed Up Turnaround' - Bloomberg News

<a href="https://www.bloomberg.com/news/articles/2025-07-02/rio-tinto-backed-aluminum-firm-to-invest-1-1-billion-in-canada-smelter" title="https://www.bloomberg.com/news/articles/2025-07-02/rio-tinto-backed-aluminum-firm-to-invest-1-1-billion-in-canada-smelter">https://www.bloomberg.com/news/articles/2025-07-02/rio-tinto-backed-aluminum-firm-to-invest-1-1-billion-in-canada-smelter</a>

Global

'Rio Tinto-Backed Aluminum Firm to Invest $1.1 Billion in Canada Project' - Bloomberg News

<a href="https://www.bloomberg.com/news/articles/2025-07-02/wells-fargo-to-ramp-up-buying-clos-after-three-year-retreat" title="https://www.bloomberg.com/news/articles/2025-07-02/wells-fargo-to-ramp-up-buying-clos-after-three-year-retreat">https://www.bloomberg.com/news/articles/2025-07-02/wells-fargo-to-ramp-up-buying-clos-after-three-year-retreat</a>

'Wells Fargo to Ramp Up Buying CLOs After Three-Year Retreat' - Bloomberg News

<a href="https://www.bloomberg.com/news/articles/2025-07-02/trump-s-tax-bill-set-to-help-sofi-other-private-student-lenders" title="https://www.bloomberg.com/news/articles/2025-07-02/trump-s-tax-bill-set-to-help-sofi-other-private-student-lenders">https://www.bloomberg.com/news/articles/2025-07-02/trump-s-tax-bill-set-to-help-sofi-other-private-student-lenders</a>

Macro Economic Events

Politics

Economics

General

SOFI

'Trump's Tax Bill Set to Help SoFi, Other Private Student Lenders' - Bloomberg News

<a href="https://www.bloomberg.com/news/articles/2025-07-02/dr-pepper-can-end-partnership-with-coke-bottler-judge-says" title="https://www.bloomberg.com/news/articles/2025-07-02/dr-pepper-can-end-partnership-with-coke-bottler-judge-says">https://www.bloomberg.com/news/articles/2025-07-02/dr-pepper-can-end-partnership-with-coke-bottler-judge-says</a>

COKE

'Dr. Pepper Can End Partnership With Coke Bottler, Judge Says' - Bloomberg News

AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) has outperformed the market over the past 20 years by 1.05% on an annualized basis producing an average annual return of 9.53%. Currently, AptarGroup has a market capitalization of $10.58 billion. 
Buying $100 In ATR: If an investor had bought $100 of ATR stock 20 years ago, it would be worth $624.91 today based on a price of $160.32 for ATR at the time of writing.
<h3>AptarGroup's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751494511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In AptarGroup 20 Years Ago Would Be Worth This Much Today

WIIM

TRIP

TripAdvisor shares are trading higher after reports that Starboard Value has built an over 9% stake in the company.

Datadog Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) shares are trading higher in Wednesday&#8217;s after-hours session after it was announced the company will <a href="https://www.benzinga.com/topic/s-p-500-index">join the S&amp;P 500</a>.
What Happened: After market close on Wednesday, S&amp;P Dow Jones Indices announced that Datadog will replace Juniper Networks in the S&amp;P 500, effective prior to the market open on July 9.
The shakeup comes after Hewlett Packard Enterprise completed its <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46172737/hpe-just-dodged-a-doj-roadblock-now-its-all-in-on-juniper-and-ai">acquisition</a> of Juniper on Wednesday. 
Datadog operates a monitoring and security platform for cloud applications.
Shares of Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), AppLovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), Interactive Brokers Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) and Carvana Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) were all trading lower at last check as they had been considered strong candidates for potential S&amp;P 500 inclusion. 
Robinhood shares were hit the hardest, last down about 2.3% in after-hours after climbing to new <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46225339/robinhood-stock-surges-to-all-time-high-on-aggressive-crypto-expansion-whats-going-on">all-time highs</a> in Wednesday&#8217;s regular session.
DDOG Price Action: <a href="http://benzinga.com/quote/DDOG">Datadog shares</a> were up 9.40% in extended trading on Wednesday, trading at $147.70 at the time of publication, per<a href="http://pro.benzinga.com"> Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46189081/what-are-stock-tokens-and-how-to-trade-them-robinhoods-new-offering-merges-owning-stocks-with-blockchain-tech-heres-how-it-works">What Are Stock Tokens And How To Trade Them? Robinhood&#8217;s New Offering Merges Owning Stocks With Blockchain Tech: Here&#8217;s How It Works</a></li>
</ul>
Photo: Shutterstock.

CVNA

DDOG

IBKR

Datadog Stock Surges On S&P 500 Inclusion

<a href="https://www.wsj.com/business/deals/starboard-takes-more-than-9-stake-in-tripadvisor-76d98d87" title="https://www.wsj.com/business/deals/starboard-takes-more-than-9-stake-in-tripadvisor-76d98d87">https://www.wsj.com/business/deals/starboard-takes-more-than-9-stake-in-tripadvisor-76d98d87</a>

'Starboard Takes More Than 9% Stake in Tripadvisor' - WSJ Excluisve

AIRE

ReAlpha Tech shares are trading higher after the company announced the launch of its AI-powered loan officer assistant.

reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) (the "Company" or "reAlpha"), an AI-powered real estate technology company, today announced the launch of its AI-powered Internal Loan Officer Assistant. This newly released AI-powered assistant is designed to streamline administrative tasks within the mortgage division, driving operational efficiency and enhancing loan processing accuracy.
The introduction of the AI Loan Officer Assistant is part of reAlpha's broader strategy to enhance its mortgage operations. This initiative builds on the Company's recent acquisitions, including Be My Neighbor and GTG Financial, which have expanded reAlpha's mortgage services footprint across 30 U.S. states.

reAlpha Launches AI-Powered Loan Officer Assistant To Boost Mortgage Efficiency

Zhibao Technology Acquires Controlling Interest in Zhonglian Jinan, More than Doubling its Branch Network and Strengthening Its Nationwide Insurance Brokerage Capabilities.
Shanghai, China--(Newsfile Corp. - July 2, 2025) - Zhibao Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAO#NASDAQ">ZBAO</a>) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced that one of its subsidiaries, Zhibao Technology Co., Ltd. ("Zhibao China"), has entered into a share purchase agreement ("Agreement") with two shareholders ("Sellers") of Zhonglian Jinan Insurance Brokers Co., Ltd. ("Zhonglian Jinan" or "Target"), and the Target, pursuant to which, subject to the terms and conditions set forth in the Agreement, Zhibao China agreed to acquire an aggregate of 51% of the equity interest in Zhonglian Jinan (the "Acquired Assets") for a total purchase price of RMB25.5 million (approximately $3.5 million) ("Purchase Price"), subject to adjustment as provided in the Agreement (the "Acquisition").
Transaction Structure and Terms
Under the Agreement, the Purchase Price is based on an evaluation of RMB 50 million for the 100% of the equity interest in Zhonglian Jinan mutually agreed by Zhibao China and Sellers and shall be paid in four installments. The first three installments, each in the amount of RMB7.65 million (approximately $1.05 million), shall be payable on July 31, 2025, July 31, 2025 and January 31, 2026, respectively. The fourth installment, in the amount of RMB 2.55 million (approximately $0.35 million), is subject to adjustment in the event that the revenue generated by the Target is less than RMB 140 million (approximately $19.18 million) within one year following the full payment of the first instalment of the Purchase Price (the "Delivery Date"). The fourth installment is payable within 30 days following the first anniversary of the Delivery Date. Additionally, Zhibao China also has a right of first refusal to acquire an additional 34% equity interests in Zhonglian Jinan by the end of 2027 (the "Subsequent Acquisition"), contingent upon Jinan achieving ongoing performance goals.
Founded in June 2015 and headquartered in Ningbo, Zhejiang, Zhonglian Jinan is a licensed insurance brokerage with a nationwide footprint comprising 28 province-level and 30 city-level branches.

ZBAO

Zhibao Technology Acquires 51% Stake In Zhonglian Jinan For ~$3.5M

Press Releases

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Quanterix Releases Financial Results for the First Quarter of 2025

Small Cap

Opinion

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Comments

Quanterix

Quanterix (QTRX) Opzioni

Quanterix (NASDAQ:QTRX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO